Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2020

View Archived Issues

Keeping stem cells quiescent enables greater ultimate potency

BioPROTACs cut out middleman, and small molecule

Tumor mutational burden correlates with high-MSI patients in CRC

SS18-SSX fusion-specific Ab for the diagnosis of synovial sarcoma

Nanoform and Orion establish drug-development collaboration

Zhuhai United Laboratories patents new JAK1 and/or TYK2 inhibitors

Primary endpoint missed in ELOQUENT-1 study of Empliciti in newly diagnosed multiple myeloma

CROI in the time of COVID-19: Researchers phoning it in at all-virtual 2020 CROI

TRPV4 found expressed in cartilaginous tumors and may be a potential therapeutic target

Kala reports promising topline data from STRIDE 3 study of Eysuvis in dry eye disease

CEL-SCI applies its LEAPS peptide technology to develop immunotherapy against COVID-19

AbbVie partners with global authorities to evaluate HIV drug for treatment of COVID-19

Dare presents data in support of sildenafil cream for female sexual arousal disorder

Encouraging 48-week data from phase III ATLAS-2M study of long-acting HIV regimen

MDM2 and CDK4 predict metastasis in Leydig cell tumors

MediciNova to develop MN-166 for severe pneumonia and ARDS

U.S. researchers present CDK8 or CDK19 inhibitors

Terns discloses new THRB agonists for NASH

Clavius Pharmaceuticals synthesizes new TGFBR1 inhibitors

Atomwise and Bridge Biotherapeutics establish AI-based research collaboration

Santen and Tracon discontinue development of DE-122 for wet AMD following phase IIa results

Acceleron ends development of ACE-083 following phase II results in Charcot-Marie-Tooth disease

Ascletis offers update on Chinese trial of Ganovo and ritonavir for novel coronavirus pneumonia

FDA approves Ofev for chronic fibrosing interstitial lung diseases with a progressive phenotype

IPH-5201 begins first-in-human study in advanced solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...